{"id":20199,"date":"2025-09-23T15:04:52","date_gmt":"2025-09-23T12:04:52","guid":{"rendered":"https:\/\/dd.deweb-servers.com\/?p=20199"},"modified":"2025-09-24T00:55:09","modified_gmt":"2025-09-23T21:55:09","slug":"tsoutsou-maria-anna","status":"publish","type":"post","link":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/tsoutsou-maria-anna\/","title":{"rendered":"Tsoutsou Maria Anna"},"content":{"rendered":"
\n
\n
\n

\u0392\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03cc<\/h3>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
Maria-Anna Tsoutsou is a Veterinarian specialized in Laboratory Animal Science. She earned her Doctor of<\/div>\n<\/div>\n<\/div>\n

Veterinary Medicine degree from the University of Thessaly in 2018, followed by a Master of Science in
\nLaboratory Animal Science from RWTH Aachen University in Germany, completed in 2022. She is certified
\nas a Laboratory Animal Science Specialist by FELASA (covering EU functions A, B, C and D) and has also
\ncompleted training in Project Management at the National and Kapodistrian University of Athens in 2023.<\/p>\n

She began her career at the Experimental Educational and Research Center of ELPEN in 2018 where she
\nprogressed from Veterinary Intern to Designated Veterinarian. Currently serving as Director of the Animal
\nCare and Use Program at Athens LifeTechPark, where she oversees all aspects of preclinical research
\ninvolving animal models. Her role includes ensuring regulatory compliance, providing input on study design,
\nand coordinating protocol development and ethical review, with a strong focus on animal welfare.<\/p>\n

In addition, she serves as a Deputy Member of the National Committee for the Protection of Animals Used
\nfor Scientific Purposes and is a peer reviewer for the journal Laboratory Animals. She is also a lecturer in
\nthe Laboratory Animal Science course Care and Use of Laboratory Animals: Mice, Rats and Zebrafish,
\norganized by the University of Crete in collaboration with the Institute of Molecular Biology and
\nBiotechnology (IMBB) at FORTH.<\/p>\n","protected":false},"excerpt":{"rendered":"

DVM, MLAS, FELASA Specialist<\/p>\n","protected":false},"author":1,"featured_media":20198,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[13],"tags":[],"class_list":["post-20199","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-personnel"],"acf":[],"_links":{"self":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts\/20199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/comments?post=20199"}],"version-history":[{"count":1,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts\/20199\/revisions"}],"predecessor-version":[{"id":20223,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts\/20199\/revisions\/20223"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/media\/20198"}],"wp:attachment":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/media?parent=20199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/categories?post=20199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/tags?post=20199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}